Investment Rating - The investment rating for the company is "Buy" with a target price not specified [6] Core Views - The company achieved a record high profit in the second quarter, with a net profit margin showing significant improvement [2] - The revenue for the first half of 2025 was CNY 12.47 billion, a year-on-year decrease of 3.6%, while the net profit attributable to the parent company was CNY 4.45 billion, an increase of 10.0% [1][3] - The company is expected to see growth in its life sciences, ultra-pure water, and lithium extraction projects, with a forecasted net profit of CNY 10.11 billion, CNY 13.22 billion, and CNY 15.96 billion for 2025-2027 [4] Revenue and Profitability - In Q2 2025, the company reported revenue of CNY 6.71 billion, a year-on-year increase of 1.1% and a quarter-on-quarter increase of 16.3% [1] - The gross margin for Q2 was 51.66%, and the net margin was 37.75%, both showing upward trends [2] - Excluding the impact of the large lithium extraction project, revenue for the first half of 2025 grew by 4.26% [3] Business Segments - The revenue from adsorption materials was CNY 10.07 billion, a year-on-year increase of 3.40%, while system device revenue decreased by 36.53% [3] - The technical service revenue saw a significant increase of 217.55%, primarily due to increased project design income in the lithium extraction sector [3] - Key projects in life sciences and ultra-pure water have made significant progress, with plans for a new high-end materials industrial park in Shaanxi Province [4] Financial Forecasts - The company’s financial projections indicate a steady increase in revenue and net profit over the next few years, with expected revenues of CNY 3.07 billion in 2025 and CNY 5.36 billion in 2027 [5] - The projected net profit for 2025 is CNY 1.01 billion, with a growth rate of 28.48% [5] Market Position - The company operates in the basic chemicals and plastics industry, with a current market capitalization of approximately CNY 26.84 billion [7] - The stock has shown a price range between CNY 37.35 and CNY 68.02 over the past year [7]

Core Viewpoint - The company reported a mixed performance for the first half of 2025, with revenue declining slightly while net profit increased, driven by high-margin product segments and improved operational efficiency [1][2]. Financial Performance - Revenue for H1 2025 was 1.247 billion yuan, a year-on-year decrease of 3.64% - Net profit attributable to shareholders was 445 million yuan, an increase of 10.01% - Operating cash flow showed a positive trend with a net cash flow of 288 million yuan, up 36.50% year-on-year [1]. Profitability - The company achieved a gross margin of 51.26% and a net margin of 35.97%, reflecting increases of 3.78 percentage points and 4.32 percentage points year-on-year, respectively - The improvement in profitability was attributed to a higher proportion of high-margin businesses in life sciences, metal resources, and ultra-pure water [1][2]. Business Segments - The company’s revenue from adsorption materials reached 1.007 billion yuan, a year-on-year growth of 3.40% - Key segments such as water treatment and ultra-pure water, life sciences, and metal resources reported revenues of 359 million yuan, 320 million yuan, and 149 million yuan, with year-on-year growth rates of 11.25%, 12.43%, and 22.84%, respectively [2]. Lithium Resource Development - The company has made significant progress in lithium extraction projects, with 12 projects completed or in execution, totaling nearly 100,000 tons of lithium carbonate/hydroxide capacity - The company is leading in lithium extraction technology and has established a benchmark project for "green zero-carbon direct lithium extraction" in Tibet [3]. Investment in Life Sciences - The company plans to invest 1.15 billion yuan in a high-end materials industrial park for life sciences in Pucheng, enhancing its capabilities in chromatography media and polymer chromatography fillers - The park will support the growth of various clinical-stage projects and has already seen positive feedback from international pharmaceutical companies [4]. Ultra-Pure Water Business - The company has increased its market penetration in the high-end drinking water sector and achieved significant breakthroughs in the ultra-pure water business - The ultra-pure water segment has secured substantial orders from leading semiconductor companies, indicating a strong market position [5]. Future Outlook - The company expects net profits attributable to shareholders to reach 1.014 billion yuan, 1.209 billion yuan, and 1.527 billion yuan for the years 2025 to 2027, with corresponding price-to-earnings ratios of 26.98X, 22.63X, and 17.92X [5].